Wednesday, August 21, 2013

Shocking News! Michael Brandon Hill Potential Child Killer Was on Psychotropic Drugs

Michael Brandon Hill entered an Atlanta Suburb school Aug. 20th of 800 or so students in pre-kindergarten through fifth grade with an AK-47 and other weapons. Just like the Sandy Hook killer did.
The suspect Michael Brandon Hill, held one or two staff members in the front office and demanded a TV to film him. If it wasn’t for a school staff member hero Antoinette Tuff, an unimposing, unarmed bookkeeper who steadfastly refused to allow him to go anywhere near the young children of her school and then convinced him to drop his weapons, empty his pockets and give himself
The suspects brother Timothy Hill told ABC news: 'I honestly can tell you he has got a long history of medical disorders, including bipolar, and that could make you snap on a dime. 'My mom's almost looked like a drugstore at one point. There was so many different medications he was on.'
He did not reveal exactly what his mental health issue but said he was taking drugs for attention-deficit hyperactivity disorder since he was six-years-old.
'I had a feeling he was going to eventually, one day, do something stupid, but not of this magnitude,' he said, adding that he once threatened to kill him.
How much more information do you need to know that psychotropic drugs kill? Who was the doctor and or psychiatrist who prescribed these medications?

Wednesday, August 14, 2013

ADHD Fraud Continues as White Kids Most Likely to be Diagnosed, Watch Out Minorities

A new study recently published in the journal Pediatrics by author Paul Morgan an associate professor of education at Pennsylvania State . This was a study of 17000 kindergarten children from 1998 to 1999 and continued to 8th grade.
Paul Morgan claims that parents of seven percent of white children reported an ADHD diagnosis. In comparison, only three percent of black children and four percent of Hispanic children had been diagnosed.
Our view and many others view is that ADHD is an absolute fraud. It is just a means of Bigpharma drug pushing and an attempt to validate invoices by Psychiatrists and uncaring Doctors. Why is it a fraud? Well it is the number one diagnosed mental health “disorder” for children in the U.S. That is a red flag because even the author admits.
There is no single test to diagnose ADHD and many of the symptoms may be associated with other causes. Hearing and visions test may be used to rule out other problems. Doctors may talk with parents, teachers and sometimes the child himself to make a diagnosis. So what happens is you have a fidgety child in a doctors office and the doctor says oh your child might have ADHD. End result the child in on an antidepressant, and labeled and screwed for life.
Here is another watch out mom: Boys are more likely to be diagnosed than girls. Being raised by an older mother and growing up in an English speaking home raised the likelihood of a diagnosis as did certain types of problem behaviors. So if you speak English to your boy, well then that child has ADHD??
The good news for minority children is that the study also found that minority children were less likely than white children to receive medication to treat ADHD. The bad news is that minority homes will be target number one from here on out. And more bad news for your child, according to the CDC: Once diagnosed, the treatments may include taking medication and behavioral therapy. They also indicate an early diagnosis can help a child reach his or her full potential.
The CDC (Center for Disease Control) is in on the fraud. All we need is an arbitrary diagnosis, and your child is on psychotropic drugs from cradle to grave?.
Could it maybe diet? Too much sugar? Lack of parental control and discipline of your child. Naw, Drugs are the answer? Right???

Wednesday, August 7, 2013

GlaxoSmithKline used a network of more than 700 Chinese travel agencies and other firms to channel bribes to health officials, state media reported Monday.

The Xinhua news agency, citing Chinese police, said four senior Chinese executives working for the U.K. pharmaceuticals group had been detained and would be charged once preliminary investigations are complete.
Since 2007, GlaxoSmithKline used the network to channel hundreds of millions of dollars to government officials, medical associations, hospitals and doctors with the aim of raising drug sales and prices, media reported.
The state news agency said the transfers totaled nearly $5 billion while other media said the figure was a tenth of that.
GlaxoSmithKline declined to comment on the number of employees held by Chinese police but said it was deeply concerned by the "shameful" allegations. It is reviewing its ties with all third-party agencies and will cooperate with the investigation.
"We have put an immediate stop on the use of travel agencies that have been identified so far in this investigation and we are conducting a thorough review of all historic transactions related to travel agency use," a spokesperson said.
China's Minister of Public Security first accused GlaxoSmithKline last week of orchestrating a campaign of bribery and corruption in some of the country's biggest cities.
International companies operating in China often have a valuable edge over local competitors in terms of public trust, but a recent spate of allegations relating to price fixing, quality control and consumer rights has forced some of them to defend their reputations. .
China claims that wrongdoing by GlaxoSmithKline executives included the falsification of tax forms in order to facilitate the payment of bribes. In addition, executives are also suspected of taking bribes and kickbacks from business partners. The security ministry said last week that the suspects had admitted to the crimes.
The GlaxoSmithKline spokesperson said the company's head of China -- Mark Reilly -- remained in his post, but declined comment on his whereabouts. Some reports say he left China last week and has not returned.
Corruption is thought to be endemic in wide swaths of Chinese industry and is perceived by many as a cost of doing business in the country.
The ruling Communist Party is sensitive to allegations of bribery after several high-profile members were caught in scandals in recent years. Former President Hu Jintao warned that failure to tackle corruption could be fatal for China.
It's not yet clear whether the GlaxoSmithKline allegations are tied to a probe of price setting practices at 60 Pharma firms announced last month by authorities.
The National Development and Reform Commission is investigating 33 drug companies over pricing and a further 27 over input costs. GlaxoSmithKline is among the companies targeted, along with Astellas and Sandoz.
Drugmakers are under pressure to reduce costs in China as the country's population grows older, a trend that is straining the country's medical system and care facilities